MGI PHARMA, INC. is an oncology-focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. MGI markets Aloxi?(palonosetron hydrochloride) injection, Salagen?Tablets (pilocarpine hydrochloride) and Hexalen?(altretamine) capsules in the United States. One of the Company's major corporate assets is its commercial organization, which is comprised of its highly experienced oncology sales organization, talented marketing team and resourceful business development group. MGI directly markets its products in the U. S. and collaborates with partners in international markets.
Search Product